Michael Schaefer

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Vascular Smooth Muscle Cells

Optical Coherence Tomography

High Throughput

Top Venues

British journal of pharmacology

Journal of biophotonics

This page only lists publications with an associated author ORCID identifier.

Publications

Rick Raudszus, Andrea Paulig, Nicole Urban, Anke Deckers, Simone Gräßle, Sylvia Vanderheiden, Nicole Jung, Stefan Bräse, Michael Schaefer, Kerstin Hill
Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages. British journal of pharmacology (2023)
Marion Maier, Stefan Olthoff, Kerstin Hill, Carolin Zosel, Thomas Magauer, Lukas Anton Wein, Michael Schaefer
KS0365, a novel activator of the transient receptor potential vanilloid 3 (TRPV3) channel, accelerates keratinocyte migration. British journal of pharmacology 179 (24) (2022)
Michael Schaefer, Hermann Kalwa
Theoretical background of light-emitting diode total internal reflection fluorescence microscopy and photobleaching lifetime analysis of membrane-associated proteins-Part II. Journal of biophotonics 13 (4) (2020)
Alexander Kogel, Hermann Kalwa, Nicole Urban, Michael Schaefer
Artifact-free objective-type multicolor total internal reflection fluorescence microscopy with light-emitting diode light sources-Part I. Journal of biophotonics 12 (11) (2019)
Stephanie Häfner, Finn Burg, Martina Kannler, Nicole Urban, Peter Mayer, Alexander Dietrich, Dirk H Trauner, Johannes Broichhagen, Michael Schaefer
A (+)-Larixol Congener with High Affinity and Subtype Selectivity toward TRPC6. ChemMedChem 13 (10) (2018)
Stefan Spyra, Anne Meisner, Michael Schaefer, Kerstin Hill
COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels. British journal of pharmacology 174 (16) (2017)
Nicole Urban, Sonja Neuser, Anika Hentschel, Sebastian Köhling, Jörg Rademann, Michael Schaefer
Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol. British journal of pharmacology 174 (22) (2017)